Geode Capital Management: Cytokinetics CYTK Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 248 M | Compra |
3,767,864
+55,363
| +1% | +USD 4.22 M | 0.01% | 675 |
|
|
2026
Q2 | USD 316 M | Compra |
3,712,501
+497,086
| +15% | +USD 35.7 M | 0.02% | 620 |
|
|
2026
Q1 | USD 212 M | Compra |
3,215,415
+159,398
| +5% | +USD 10.1 M | 0.01% | 709 |
|
|
2025
Q4 | USD 194 M | Compra |
3,056,017
+15,815
| +0.5% | +USD 984 k | 0.01% | 731 |
|
|
2025
Q3 | USD 167 M | Compra |
3,040,202
+45,757
| +2% | +USD 1.89 M | 0.01% | 781 |
|
|
2025
Q2 | USD 98.9 M | Compra |
2,994,445
+56,961
| +2% | +USD 1.98 M | 0.01% | 1033 |
|
|
2025
Q1 | USD 118 M | Compra |
2,937,484
+96,146
| +3% | +USD 4.42 M | 0.01% | 880 |
|
|
2024
Q4 | USD 134 M | Venta |
2,841,338
-7,246
| -0.3% | -USD 376 k | 0.01% | 821 |
|
|
2024
Q3 | USD 150 M | Compra |
2,848,584
+109,938
| +4% | +USD 6.13 M | 0.01% | 746 |
|
|
2024
Q2 | USD 148 M | Compra |
2,738,646
+491,481
| +22% | +USD 29.7 M | 0.01% | 699 |
|
|
2024
Q1 | USD 158 M | Compra |
2,247,165
+157,040
| +8% | +USD 12.1 M | 0.01% | 688 |
|
|
2023
Q4 | USD 175 M | Compra |
2,090,125
+111,760
| +6% | +USD 4.05 M | 0.02% | 595 |
|
|
2023
Q3 | USD 58.3 M | Compra |
1,978,365
+69,134
| +4% | +USD 2.3 M | 0.01% | 1134 |
|
|
2023
Q2 | USD 62.3 M | Compra |
1,909,231
+174,535
| +10% | +USD 6.46 M | 0.01% | 1087 |
|
|
2023
Q1 | USD 61 M | Compra |
1,734,696
+76,846
| +5% | +USD 3.13 M | 0.01% | 1045 |
|
|
2022
Q4 | USD 76 M | Compra |
1,657,850
+66,392
| +4% | +USD 2.86 M | 0.01% | 870 |
|
|
2022
Q3 | USD 77.1 M | Compra |
1,591,458
+107,936
| +7% | +USD 5.19 M | 0.01% | 801 |
|
|
2022
Q2 | USD 58.3 M | Compra |
1,483,522
+11,611
| +0.8% | +USD 467 k | 0.01% | 1002 |
|
|
2022
Q1 | USD 54.2 M | Compra |
1,471,911
+43,289
| +3% | +USD 1.54 M | 0.01% | 1198 |
|
|
2021
Q4 | USD 65.1 M | Compra |
1,428,622
+30,574
| +2% | +USD 1.18 M | 0.01% | 1109 |
|
|
2021
Q3 | USD 50 M | Compra |
1,398,048
+187,626
| +16% | +USD 5.52 M | 0.01% | 1277 |
|
|
2021
Q2 | USD 24 M | Compra |
1,210,422
+52,294
| +5% | +USD 1.23 M | ﹤0.01% | 1846 |
|
|
2021
Q1 | USD 26.9 M | Compra |
1,158,128
+102,567
| +10% | +USD 2.19 M | ﹤0.01% | 1687 |
|
|
2020
Q4 | USD 21.9 M | Compra |
1,055,561
+52,615
| +5% | +USD 962 k | ﹤0.01% | 1663 |
|
|
2020
Q3 | USD 21.7 M | Compra |
1,002,946
+131,880
| +15% | +USD 3.08 M | ﹤0.01% | 1484 |
|
|
2020
Q2 | USD 20.5 M | Compra |
871,066
+13,310
| +2% | +USD 250 k | ﹤0.01% | 1493 |
|
|
2020
Q1 | USD 10.1 M | Compra |
857,756
+57,784
| +7% | +USD 737 k | ﹤0.01% | 1736 |
|
|
2019
Q4 | USD 8.49 M | Compra |
799,972
+8,303
| +1% | +USD 85.3 k | ﹤0.01% | 2129 |
|
|
2019
Q3 | USD 9.01 M | Compra |
791,669
+37,536
| +5% | +USD 471 k | ﹤0.01% | 2011 |
|
|
2019
Q2 | USD 8.48 M | Compra |
754,133
+82,998
| +12% | +USD 800 k | ﹤0.01% | 2064 |
|
|
2019
Q1 | USD 5.43 M | Compra |
671,135
+85,592
| +15% | +USD 629 k | ﹤0.01% | 2284 |
|
|
2018
Q4 | USD 3.7 M | Compra |
585,543
+70,954
| +14% | +USD 521 k | ﹤0.01% | 2409 |
|
|
2018
Q3 | USD 5.07 M | Compra |
514,589
+18,139
| +4% | +USD 146 k | ﹤0.01% | 2349 |
|
|
2018
Q2 | USD 4.12 M | Compra |
496,450
+62,330
| +14% | +USD 519 k | ﹤0.01% | 2434 |
|
|
2018
Q1 | USD 3.12 M | Compra |
434,120
+5,572
| +1% | +USD 47.8 k | ﹤0.01% | 2513 |
|
|
2017
Q4 | USD 3.49 M | Compra |
428,548
+6,813
| +2% | +USD 77.3 k | ﹤0.01% | 2430 |
|
|
2017
Q3 | USD 6.12 M | Venta |
421,735
-26,541
| -6% | -USD 363 k | ﹤0.01% | 2074 |
|
|
2017
Q2 | USD 5.42 M | Compra |
448,276
+151,593
| +51% | +USD 2.11 M | ﹤0.01% | 2094 |
|
|
2017
Q1 | USD 3.81 M | Compra |
296,683
+11,747
| +4% | +USD 137 k | ﹤0.01% | 2270 |
|
|
2016
Q4 | USD 3.46 M | Compra |
284,936
+11,268
| +4% | +USD 120 k | ﹤0.01% | 2293 |
|
|
2016
Q3 | USD 2.51 M | Compra |
273,668
+1,817
| +0.7% | +USD 19 k | ﹤0.01% | 2424 |
|
|
2016
Q2 | USD 2.58 M | Venta |
271,851
-6,979
| -3% | -USD 57.3 k | ﹤0.01% | 2322 |
|
|
2016
Q1 | USD 1.96 M | Venta |
278,830
-47,250
| -14% | -USD 345 k | ﹤0.01% | 2476 |
|
|
2015
Q4 | USD 3.41 M | Compra |
326,080
+41,767
| +15% | +USD 410 k | ﹤0.01% | 2133 |
|
|
2015
Q3 | USD 1.9 M | Compra |
284,313
+87,835
| +45% | +USD 600 k | ﹤0.01% | 2477 |
|
|
2015
Q2 | USD 1.32 M | Compra |
196,478
+1,402
| +0.7% | +USD 9.19 k | ﹤0.01% | 2753 |
|
|
2015
Q1 | USD 1.32 M | Compra |
195,076
+33,434
| +21% | +USD 250 k | ﹤0.01% | 2704 |
|
|
2014
Q4 | USD 1.29 M | Compra |
161,642
+231
| +0.1% | +USD 991 | ﹤0.01% | 2683 |
|
|
2014
Q3 | USD 568 k | Compra |
161,411
+3,088
| +2% | +USD 13 k | ﹤0.01% | 3106 |
|
|
2014
Q2 | USD 756 k | Compra |
158,323
+2,776
| +2% | +USD 16.9 k | ﹤0.01% | 2966 |
|
|
2014
Q1 | USD 1.48 M | Compra |
155,547
+32,582
| +26% | +USD 295 k | ﹤0.01% | 2528 |
|
|
2013
Q4 | USD 799 k | Compra |
122,965
+1,833
| +2% | +USD 12 k | ﹤0.01% | 2853 |
|
|
2013
Q3 | USD 919 k | Compra |
121,132
+29,644
| +32% | +USD 318 k | ﹤0.01% | 2640 |
|
|
2013
Q2 | USD 1.06 M | Compra |
+91,488
| Nuevas | +USD 721 k | ﹤0.01% | 2432 |
|
Otros fondos que tienen CYTK en su portafolio
Posición de Geode Capital Management en CYTK: resumen de T3 2026
Geode Capital Management aumentó su participación en Cytokinetics (CYTK) en 1.5% durante T3 2026, al comprar aproximadamente USD 4.22 M y elevar la posición a 3,767,864 acciones con un valor de USD 248 M. La posición representa 0.01% del portafolio y ocupa el puesto #675.
Geode Capital Management reportó por primera vez una posición en CYTK en T2 2013 y desde entonces la ha mantenido en 54 trimestres. La posición alcanzó su máximo de USD 316 M en T2 2026. Al cierre de T3 2026, 470 fondos que sigue Wall St. Rank mantienen una posición en CYTK.
- Al cierre de T3 2026, Geode Capital Management tenía 3,767,864 acciones de Cytokinetics con un valor de USD 248 M.
- Geode Capital Management compró 55,363 acciones de Cytokinetics en T3 2026, por un monto estimado de USD 4.22 M.
- Cytokinetics representó el 0.01% del portafolio de Geode Capital Management en T3 2026 y fue su posición número 675.
- Geode Capital Management reportó por primera vez una posición en Cytokinetics en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- La posición de Geode Capital Management en Cytokinetics alcanzó su máximo de USD 316 M en T2 2026.
- Al cierre de T3 2026, 470 fondos que sigue Wall St. Rank tenían Cytokinetics en su portafolio.
Según el informe 13F de Geode Capital Management correspondiente a T3 2026, presentado el 6 nov 2026.